Howard B. Rosen
Equibles does not estimate personal net worth.
About Howard B. Rosen
Howard B. Rosen was last confirmed as Board Member at KALA BIO, Inc. (KALA) in a filing dated December 30, 2025. Earlier roles on record: Board Member at KALA BIO, Inc. (KALA) until December 19, 2025. KALA BIO, Inc. reported in an 8-K filed February 2, 2026 that Howard B. Rosen resigned as Class III director, effective December 19, 2025. The same filing states: “Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen’s resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.” KALA BIO, Inc. reported in an 8-K filed December 29, 2025 that Howard B. Rosen resigned as director. The same filing states: “The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.” KALA BIO, Inc. reported in an 8-K filed June 23, 2023 that Howard B. Rosen was appointed Class III director, effective June 22, 2023.
“on December 19, 2025, each of (i) Marjan Farid, M.D. and Andrew I. Koven, who were Class I directors of the Company, (ii) Mark Iwicki and Todd Bazemore were Class II directors of the Company, and (iii) C. Daniel Meyers and Howard B. Rosen, who were Class III directors of the Company (collectively, the "Resigning Directors"), tendered their resignations as directors of the Company, effective immediately following the Annual Meeting and upon approval of the Issuance Proposal and the Share Increase Proposal”
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen’s resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
“each of Marjan Farid, M.D., Andrew I. Koven, C. Daniel Myers, Todd Bazmore, Mark Iwicki, and Howard B. Rosen tendered on December 19, 2025 a conditional resignation from their positions as director effective immediately after the Company's 2025 Annual Meeting if stockholder approval is obtained at such 2025 Annual Meeting”
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Affiliation history
-
Start not stated–2025-12-30
Last confirmed by a filing; no departure on record
-
Start not stated–2025-12-19
Company network
Recent activity
-
Executive change Resigned: director
“The resignations were not due to any disagreement with the Company on any matter relating to its operations, policies or practices.”
KALA BIO, Inc. (KALA) -
Executive change Resigned: Class III director
“Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen’s resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
KALA BIO, Inc. (KALA) -